K Number
K231718
Date Cleared
2023-08-18

(66 days)

Product Code
Regulation Number
878.4810
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The Holmium Medical Laser and its fiber optic delivery system are in surgical procedures using open, laparoscopic and endoscopic incision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue in use in medical specialties including: Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectory, Gynecology, ENT, Pulmonary Surgery and General Surgery.

Urology
Open and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Urethral Strictures
  • · Bladder Neck Incisions (BNI)
  • · Ablation and resection of Bladder Tumors, Uretheral Tumors and Ureteral Tumors,
  • · Ablation of Benign Prostatic Hypertrophy (BPH),
  • · Transurethral incision of the prostate (TUIP)
  • · Holmium Laser Resection of the Prostrate (HoLRP)
  • · Holmium Laser Enucleation of the Prostate (HoLEP)
  • · Holmium laser Ablation of the Prostate (HoLAP)
  • · Condylomas
  • · Lesions of external genitalia

Lithotripsy and Percutaneous Urinary Lithotripsy
· Endoscopic fragmentation of ureteral, bladder and renal calculi including cystine, calcium oxalate,

  • monohydrate and calcium oxalate
  • · dehydrate stones.
  • · Endoscopic fragmentation of kidney calculi.
  • · Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed.

Gastroenterology
Open and endoscopic Gastroenterology surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Appendectomy
  • Polyps
  • · Biopsy
  • · Gall Bladder calculi
  • · Biliary/Bile duct calculi
  • · Ulcers
  • · Gastric ulcers
  • · Duodenal ulcers
  • · Non Bleeding Ulcers
  • · Pancreatitas
  • · Haemorrhoids
  • · Cholecystectomy
  • · Benign and Malignant Neoplasm
  • · Angiodysplasia
  • · Colorectal cancer
    · Telangiectasias
  • · Telangiectasias of the Osler-Weber-Renu disease
  • Vascular Malformation
  • · Gastritis
  • · Esophagitis
  • · Esophageal ulcers
  • Varices
  • · Colitis
  • · Mallory-Weiss tear
  • · Gastric Erosions

Arthroscopy
Arthroscopy/Orthopaedic surgery (excision, ablation and coagulation of soft and cartilaginous tissue) in small and large joints of the body, excluding the spine but including:

  • · Ligament and tendon Release
  • · Contouring and sculpting of articular surfaces
  • · Capsulectomy in the Knee
  • · Chondreplasty in the Knee
  • · Debridement of inflamed synovial tissue
  • Chondromalacia Ablation
  • · Chondromalacia and tears
  • · Plica Removal
  • · Meniscectomy
  • · Loose Body Debridement
  • · Lateral retinecular release

Ablation of soft, cartilaginous and bony tissue in Minimal Invasive Spinal Surgery including
· Percutaneous Laser Disc Decompression/Discectomy of the L4-5 and L5-S1 lumbar discs, including Foraminoplasty Percutaneous Cervical Disc Decompression/Discectomy
Percutaneous Thoracic Disc Decompression/Discectomy

Gynaecology
Open and laparoscopic gynaecological surgery (incision, excision, ablation, vaporization, coagulation and haemostasis) of soft tissue

ENT
Endoscopic endonasal surgery (incision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue and cartilage) including:

  • · Endonasal/sinus Surgery
  • · Partial turbinectomy
  • · Polypectomy
  • · Dacryocystorhinostomy
  • · Frontal Sinusotomy
  • · Ethmoidectomy
  • · Maxillary antrostomy
  • · Functional endoscopic sinus surgery

Pulmonary Surgery
Open and endoscopic pulmonary surgery (cutting, vaporization, incision and coagulation of soft tissue)

General Surgery
Open, laparoscopic and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Appendectomy
    · Skin incision
  • · Excision of external and internal lesions
  • · Complete or partial resection of internal organs, turnors and lesions
  • · Biopsy
Device Description

The devices belonging to Holmium laser family are laser devices based on a Holmium laser source. The main parts (subsystems) of the device are the Holmium laser source, the power electronics, the optical delivery system, the control electronics and the cooling system. Specific software controls the device functions and allows the user selections. Laser emission is triggered by a footswitch.

AI/ML Overview

The provided document is a 510(k) summary for a medical device called "Holmium Medical Laser." It demonstrates substantial equivalence to predicate devices, which means it has similar intended use, technological characteristics, and safety/efficacy profile to devices already legally marketed in the U.S.

However, the document does NOT describe a study that proves the device meets specific acceptance criteria based on metrics like sensitivity, specificity, or reader performance with and without AI assistance. This type of study is typically done for AI/ML-enabled devices that rely on complex algorithms for diagnosis or analysis, often involving image interpretation.

The Holmium Medical Laser is a surgical instrument, a hardware device that emits laser energy for various surgical procedures. The testing described is primarily focused on safety and performance standards for a physical device, not an AI algorithm.

Therefore, many of the requested details from your prompt, such as "multireader multicase study," "effect size of how much human readers improve with AI," "standalone algorithm performance," "type of ground truth (expert consensus, pathology, outcomes data)," and "training set details," are not applicable to the information provided in this 510(k) summary for a "Holmium Medical Laser."

Based on the provided document, here's what can be extracted regarding acceptance criteria and performance, reinterpreted for a physical medical device:


1. A table of acceptance criteria and the reported device performance:

For a physical medical device like a laser, "acceptance criteria" and "reported device performance" are typically defined by adherence to recognized electrical, laser safety, and risk management standards. The document states that the device was tested in compliance with these standards.

Acceptance Criterion (Standard)Reported Device Performance
ISO 14971: 2019 (Risk Management)Risk analysis activities in compliance.
IEC 60601-1:2005+ (General Requirements for Basic Safety and Essential Performance)Electrical and laser safety tests in compliance.
IEC 60601-1-2:2014 (Electromagnetic Compatibility)Electromagnetic compatibility tests in compliance.
IEC 60601-2-22: 2007+A1:2012 (Particular Requirements for Surgical Laser Equipment)Medical electrical equipment specific requirements tests in compliance.
IEC 60825-1:2014 (Safety of Laser Products - Equipment classification and requirements)Safety of laser products tests in compliance.
FDA Guidance for Premarket Submissions for Software Contained in Medical Devices (2005)Software verification and validations performed.
Functional Performance (e.g., Wavelength, Power)The tests verified that the subject Holmium Medical Laser performs according to its specifications. Specifics (Pulse Duration, Pulse Frequency, Pulse Energy, Max Average Power) are listed and considered "Similar" or "Same" to predicate.

2. Sample size used for the test set and the data provenance:

  • Sample Size: Not applicable in the context of clinical test sets for AI/ML. The "testing" refers to verification and validation of engineering specifications and compliance with safety standards, not a clinical trial on patient data.
  • Data Provenance: Not applicable for device safety and performance testing.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

  • Not applicable. Ground truth as understood in AI/ML (e.g., expert annotations on images) is not relevant for this type of device submission. Safety and performance are established through engineering tests and adherence to established standards.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

  • Not applicable. This refers to consensus methods for expert labeling in AI/ML datasets.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • No. This is a hardware surgical laser, not an AI-assisted diagnostic tool. Therefore, MRMC studies are not relevant.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

  • Not applicable. The device is a surgical laser, directly operated by a human surgeon. There is no "standalone algorithm" performance to evaluate.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

  • Not applicable in the AI/ML context. The "ground truth" for this device's performance is adherence to established engineering specifications, safety standards, and functional requirements (e.g., laser output measurements, electrical safety checks).

8. The sample size for the training set:

  • Not applicable. This device is not an AI/ML model that requires a training set.

9. How the ground truth for the training set was established:

  • Not applicable.

In summary, the provided document is a 510(k) premarket notification for a physical medical device (Holmium Medical Laser) and details its substantial equivalence to predicate devices by demonstrating compliance with established safety and performance standards. It does not contain information related to AI/ML device acceptance criteria or studies involving clinical image interpretation, which is what your detailed prompt questions are geared towards.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the text "FDA U.S. FOOD & DRUG ADMINISTRATION" on the right. The symbol on the left is a stylized representation of a human figure, while the text on the right is written in a clear, sans-serif font. The FDA logo is a recognizable symbol of the agency's mission to protect and promote public health.

August 18, 2023

Allengers Global Healthcare Private Limited Harpreet Singh Director-Technical Room No.5, Khasra no. 79, Bhankarpur, Mubarakpur Road Derabassi, District- Mohali, Punjab 140507 India

Re: K231718

Trade/Device Name: Holmium Medical Laser Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument For Use In General And Plastic Surgery And In Dermatology Regulatory Class: Class II Product Code: GEX Dated: May 5, 2023 Received: June 13, 2023

Dear Harpreet Singh:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

Digitally signed by Tanish Tanisha L. 0ate: 2023.08.18 15:22:10 Hithe -S

Tanisha Hithe, MS, MHS Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K231718

Device Name

Holmium Medical Laser

The Holmium Medical Laser and its fiber optic delivery system are in surgical procedures using open, laparoscopic and endoscopic incision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue in use in medical specialties including: Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectory, Gynecology, ENT, Pulmonary Surgery and General Surgery.

Urology

Open and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Urethral Strictures
  • · Bladder Neck Incisions (BNI)
  • · Ablation and resection of Bladder Tumors, Uretheral Tumors and Ureteral Tumors,
  • · Ablation of Benign Prostatic Hypertrophy (BPH),
  • · Transurethral incision of the prostate (TUIP)
  • · Holmium Laser Resection of the Prostrate (HoLRP)
  • · Holmium Laser Enucleation of the Prostate (HoLEP)
  • · Holmium laser Ablation of the Prostate (HoLAP)
  • · Condylomas
  • · Lesions of external genitalia

Lithotripsy and Percutaneous Urinary Lithotripsy

· Endoscopic fragmentation of ureteral, bladder and renal calculi including cystine, calcium oxalate,

  • monohydrate and calcium oxalate
  • · dehydrate stones.
  • · Endoscopic fragmentation of kidney calculi.
  • · Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed.

Gastroenterology

Open and endoscopic Gastroenterology surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Appendectomy
  • Polyps
  • · Biopsy
  • · Gall Bladder calculi
  • · Biliary/Bile duct calculi
  • · Ulcers
  • · Gastric ulcers
  • · Duodenal ulcers
  • · Non Bleeding Ulcers
  • · Pancreatitas
  • · Haemorrhoids
  • · Cholecystectomy
  • · Benign and Malignant Neoplasm
  • · Angiodysplasia
  • · Colorectal cancer

{3}------------------------------------------------

· Telangiectasias

  • · Telangiectasias of the Osler-Weber-Renu disease
  • Vascular Malformation
  • · Gastritis
  • · Esophagitis
  • · Esophageal ulcers
  • Varices
  • · Colitis
  • · Mallory-Weiss tear
  • · Gastric Erosions

Arthroscopy

Arthroscopy/Orthopaedic surgery (excision, ablation and coagulation of soft and cartilaginous tissue) in small and large joints of the body, excluding the spine but including:

  • · Ligament and tendon Release
  • · Contouring and sculpting of articular surfaces
  • · Capsulectomy in the Knee
  • · Chondreplasty in the Knee
  • · Debridement of inflamed synovial tissue
  • Chondromalacia Ablation
  • · Chondromalacia and tears
  • · Plica Removal
  • · Meniscectomy
  • · Loose Body Debridement
  • · Lateral retinecular release

Ablation of soft, cartilaginous and bony tissue in Minimal Invasive Spinal Surgery including

· Percutaneous Laser Disc Decompression/Discectomy of the L4-5 and L5-S1 lumbar discs, including Foraminoplasty Percutaneous Cervical Disc Decompression/Discectomy

Percutaneous Thoracic Disc Decompression/Discectomy

Gynaecology

Open and laparoscopic gynaecological surgery (incision, excision, ablation, vaporization, coagulation and haemostasis) of soft tissue

ENT

Endoscopic endonasal surgery (incision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue and cartilage) including:

  • · Endonasal/sinus Surgery
  • · Partial turbinectomy
  • · Polypectomy
  • · Dacryocystorhinostomy
  • · Frontal Sinusotomy
  • · Ethmoidectomy
  • · Maxillary antrostomy
  • · Functional endoscopic sinus surgery

Pulmonary Surgery

Open and endoscopic pulmonary surgery (cutting, vaporization, incision and coagulation of soft tissue)

General Surgery

Open, laparoscopic and endoscopic surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • · Appendectomy

{4}------------------------------------------------

· Skin incision

  • · Excision of external and internal lesions
  • · Complete or partial resection of internal organs, turnors and lesions
  • · Biopsy

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{5}------------------------------------------------

SECTION 5

510(k) Summary K231718

{6}------------------------------------------------

510(k) SUMMARY

(K231718)

This summary of 510(k) is being submitted in accordance with requirements of 21 CFR Part 807.92

Applicant /ManufacturerName and AddressAllengers Global Healthcare Private LimitedRoom No.5, Khasra no. 79, Bhankarpur, Mubarakpur Road, Derabassi,District- Mohali, 140507, Punjab (India)
+911762-272600
510(K) Contact personHarpreet SinghAddress: Room No.5, Khasra no. 79, Bhankarpur, Mubarakpur Road,Derabassi, District- Mohali, 140507, Punjab (India)Contact Number: +919876615337Email ID: harpreet.singh@allengers.net
Date Prepared5th May, 2023
Device/Trade NameHolmium Medical Laser
Models NamesBLAZE-prime, BLAZE
Regulation ClassClass II
Regulation NameLaser Surgical Instrument For Use In General And Plastic Surgery AndIn Dermatology
Regulation Number21 CFR 878.4810
Product CodeGEX
PanelGeneral and Plastic Surgery
Predicate DevicesCyber Ho 100 (K192600)-Quanta system spa
Reference DevicesEmpower H65(K180423), Litho(K163009)- Quanta system spaLumenis Pulse 120H (K170121)-Lumenis Ltd.

{7}------------------------------------------------

Device Description

The devices belonging to Holmium laser family are laser devices based on a Holmium laser source. The main parts (subsystems) of the device are the Holmium laser source, the power electronics, the optical delivery system, the control electronics and the cooling system. Specific software controls the device functions and allows the user selections. Laser emission is triggered by a footswitch.

FeatureSubject DevicePredicate DeviceJustificationfordifferences
ManufacturerAllengers Global Healthcare Pvt.Ltd.Quanta System SPA
ModelsBLAZE-prime(100W,65W)BLAZE(35W)Cyber Ho 100
510(k)K231718K192600
ManufacturerAllengers Global Healthcare Pvt.Ltd.Quanta System SPA
Device/TradeNameHolmium Medical LaserCyber Ho 100
Laser MediumPulsed Holmium laser (CTH:YAG)Pulsed Holmium laser(CTH:YAG)Same
Wavelength2100nm2100nmSame
EmissionPulsedPulsedSame
Pulse Duration95- 1500μs50 - 1100 μsSimilar
Pulse Frequency3-80HZ (100W)3-60HZ (65W)3-30HZ3-80 HzSame
Pulse Energy0.1J to 5JUpto 5JSame
MaximumAverage PowerUp to 100 W(100W)Up to 65 W(65W)Up to 35 WUp to 105WSimilar
Delivery SystemOptical FiberOptical FiberSame
Aiming Beam
TypeDPSSDPSSSame
PowerPower <5mWPower <5mWSame
WavelengthWavelength 532nmWavelength 532nmSame
Laser ClassClass 3RClass 3RSame

Summary of Technical Characteristic

Intended Use/ Indications for Use:

The Holmium Medical Laser and its fiber optic delivery system are intended for use in surgical procedures using open, laparoscopic and endoscopic incision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue in use in medical specialties including: Urology, Urinary Lithotripsy, Gastroenterology, Arthroscopy, Discectomy, Gynecology, ENT, Pulmonary Surgery and General Surgery

{8}------------------------------------------------

Urology

Open and endoscopic surgery (incision, excision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • Urethral Strictures
  • Bladder Neck Incisions (BNI) ●
  • Ablation and resection of Bladder Tumors, Uretheral Tumors and Ureteral Tumors, ●
  • Ablation of Benign Prostatic Hypertrophy (BPH),
  • Transurethral incision of the prostate (TUIP)
  • Holmium Laser Resection of the Prostrate (HoLRP)
  • Holmium Laser Enucleation of the Prostate (HoLEP)
  • Holmium laser Ablation of the Prostate (HoLAP) .
  • Condylomas ●
  • . Lesions of external genitalia

Lithotripsy and Percutaneous Urinary Lithotripsy

  • Endoscopic fragmentation of urethral, ureteral, bladder and renal calculi including cystine, calcium oxalate, monohydrate and calcium oxalate
  • dehydrate stones.
  • Endoscopic fragmentation of kidney calculi. ●
  • Treatment of distal impacted fragments of steinstrasse when guide wire cannot be passed. .

Gastroenterology

Open and endoscopic Gastroenterology surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) including:

  • Appendectomy ●
  • Polyps ●
  • Biopsy ●
  • Gall Bladder calculi ●
  • Biliary/Bile duct calculi
  • Ulcers
  • Gastric ulcers ●
  • Duodenal ulcers ●
  • Non Bleeding Ulcers
  • Pancreatitas
  • . Haemorrhoids
  • . Cholecystectomy
  • Benign and Malignant Neoplasm
  • Angiodysplasia
  • Colorectal cancer
  • Telangiectasias
  • Telangiectasias of the Osler-Weber-Renu disease
  • Vascular Malformation
  • Gastritis ●
  • Esophagitis
  • Esophageal ulcers
  • Varices ●
  • Colitis ●
  • Mallory-Weiss tear ●
  • Gastric Erosions ●

{9}------------------------------------------------

Arthroscopy

Arthroscopy/Orthopaedic surgery (excision, ablation and coagulation of soft and cartilaginous tissue) in small and large joints of the body, excluding the spine but including:

  • Ligament and tendon Release
  • . Contouring and sculpting of articular surfaces
  • Capsulectomy in the Knee ●
  • Chondreplasty in the Knee
  • Debridement of inflamed synovial tissue
  • Chondromalacia Ablation
  • Chondromalacia and tears
  • . Plica Removal
  • Meniscectomy ●
  • Loose Body Debridement ●
  • Lateral retinecular release ●

Ablation of soft, cartilaginous and bony tissue in Minimal Invasive Spinal Surgery including

  • Percutaneous Laser Disc Decompression/Discectomy of the L4-5 and L5-SI lumbar discs, ● including Foraminoplasty Percutaneous Cervical Disc Decompression/Discectomy Percutaneous Thoracic Disc Decompression/Discectomy

Gynaecology

Open and laparoscopic gynaecological surgery (incision, resection, ablation, vaporization, coagulation and haemostasis) of soft tissue

ENT

Endoscopic endonasal surgery (incision, excision, resection, ablation, vaporization, coagulation and haemostasis of soft tissue and cartilage) including:

  • Endonasal/sinus Surgery ●
  • Partial turbinectomy
  • Polypectomy ●
  • Dacryocystorhinostomy ●
  • Frontal Sinusotomy ●
  • Ethmoidectomy ●
  • Maxillary antrostomy ●
  • . Functional endoscopic sinus surgery

Pulmonary Surgery

Open and endoscopic pulmonary surgery (cutting, vaporization, excision and coagulation of soft tissue)

General Surgery

Open, laparoscopic and endoscopic surgery (incision, excision, ablation, vaporization, coagulation and haemostasis) including:

  • Appendectomy ●
  • . Skin incision
  • Excision of external and internal lesions ●
  • Complete or partial resection of internal organs, tumors and lesions ●
  • Biopsy

{10}------------------------------------------------

Accessories

The device is intended to be used together with delivery optical fiber that separately received a FDA clearance for an intended use.

Performance Testing

The Subject device performs testing in accordance with the following recognized consensus standards

  • Risk analysis activities, in compliance with the requirements of ISO 14971: 2019 Medical devices - Application of Risk Management to Medical Devices.
  • Electrical and laser safety and electromagnetic compatibility tests, in compliance with: ● IEC 60601-1:2005+ CORR.1:2006+CORR. 2:2007 +AM1:2012 Medical Electrical O Equipment - Part 1: General Requirements for Basic Safety and Essential Performance.
    • O IEC 60601-1-2:2014, Medical Electrical Equipment - Part 1-2: General Requirements for Basic Safety and Essential Performance Collateral Standard: Electromagnetic Compatibility - Requirements and Tests.
    • IEC 60601-2-22: 2007+A1:2012 Medical Electrical Equipment -Part 2-22: Particular O Requirements For Basic Safety And Essential Performance of Surgical, Cosmetic, Therapeutic And Diagnostic Laser Equipment.
    • IEC 60825-1:2014 Safety of laser products Part 1: Equipment classification and O requirements.
  • . Software verification and validations, in compliance with FDA Guidance for the Premarket Submissions for Software Contained in Medical Devices (issue on 2005). The tests verified that the subject Holmium Medical Laser performs according to its specifications.

Comparison with predicate device

The subject device technological characteristics and indication for use are same to the predicate device and its output power ranges are similar to those of the predicate devices. Other difference between the subject device and predicate device is not raise new types of question regarding the subject device's safety and efficacy.

Conclusion

The Holmium Medical Laser do not introduces any new indications for use, nor does the use of the systems result in any new potential hazard. The Holmium Medical Laser, the subject device is substantially equivalent to the predicate and reference device Cyber Ho100 (K192600), Empower65 (K180423), Litho (K163009), Lumenis pulse120H (K170121).

The intended use, the design principle and the applicable standards for the subject device to those of the predicate and reference device. Some characteristics, for example, their appearance, user interface and the physical dimension are different. However performance test result demonstrates that these differences do not raise any new question of safety and effectives. Therefore, it is Allengers Global Healthcare Pvt. Ltd. option that the subject device appears to be as safe and effective as the predicate and reference device.

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.